Switch theme
Sign up to access all valuation multiples
Inventurus Knowledge Solutions Ltd is a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the USA, Canada and Australia, with a focus on the USAÂ markets. It is partner for outpatient and inpatient care organizations, enabling healthcare organizations deliver superior clinical care, improve population health outcomes, and transition to the fee for value model while optimizing their revenue and reducing operating costs, It has nearly 778 healthcare organizations as clients, including health systems, academic medical centers, multi-specialty medical groups, single specialty medical groups, ancillary healthcare organizations and other outpatient and inpatient healthcare delivery organization.
2006
13.5K+
LTM Revenue $289M
LTM EBITDA $82.3M
$2.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
IKS Health has a last 12-month revenue of $289M and a last 12-month EBITDA of $82.3M.
In the most recent fiscal year, IKS Health achieved revenue of $211M and an EBITDA of $64.9M.
IKS Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See IKS Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $120M | $211M | XXX | XXX | XXX |
| Gross Profit | $88.7M | $120M | XXX | XXX | XXX |
| Gross Margin | 74% | 57% | XXX | XXX | XXX |
| EBITDA | $45.2M | $64.9M | XXX | XXX | XXX |
| EBITDA Margin | 38% | 31% | XXX | XXX | XXX |
| Net Profit | $27.1M | $35.5M | XXX | XXX | XXX |
| Net Margin | 23% | 17% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, IKS Health's stock price is INR 1341 (or $16).
IKS Health has current market cap of INR 224B (or $2.6B), and EV of INR 230B (or $2.7B).
See IKS Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.7B | $2.6B | XXX | XXX | XXX | XXX | $0.33 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, IKS Health has market cap of $2.6B and EV of $2.7B.
IKS Health's trades at 9.3x LTM EV/Revenue multiple, and 32.5x LTM EBITDA.
Analysts estimate IKS Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for IKS Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.7B | XXX | XXX | XXX |
| EV/Revenue | 10.0x | XXX | XXX | XXX |
| EV/EBITDA | 34.6x | XXX | XXX | XXX |
| P/E | 27.6x | XXX | XXX | XXX |
| P/E/Growth | 1.1x | XXX | XXX | XXX |
| EV/FCF | 64.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpIKS Health's NTM/LTM revenue growth is 22%
IKS Health's revenue per employee for the last fiscal year averaged $16K, while opex per employee averaged $12K for the same period.
Over next 12 months, IKS Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate IKS Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for IKS Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 76% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 44% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 51% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $16K | XXX | XXX | XXX | XXX |
| Opex per Employee | $12K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 74% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
IKS Health acquired XXX companies to date.
Last acquisition by IKS Health was XXXXXXXX, XXXXX XXXXX XXXXXX . IKS Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was IKS Health founded? | IKS Health was founded in 2006. |
| Where is IKS Health headquartered? | IKS Health is headquartered in India. |
| How many employees does IKS Health have? | As of today, IKS Health has 13.5K+ employees. |
| Is IKS Health publicy listed? | Yes, IKS Health is a public company listed on NSE. |
| What is the stock symbol of IKS Health? | IKS Health trades under IKS ticker. |
| When did IKS Health go public? | IKS Health went public in 2024. |
| Who are competitors of IKS Health? | Similar companies to IKS Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of IKS Health? | IKS Health's current market cap is $2.6B |
| What is the current revenue of IKS Health? | IKS Health's last 12-month revenue is $289M. |
| What is the current EBITDA of IKS Health? | IKS Health's last 12-month EBITDA is $82.3M. |
| What is the current EV/Revenue multiple of IKS Health? | Current revenue multiple of IKS Health is 9.3x. |
| What is the current EV/EBITDA multiple of IKS Health? | Current EBITDA multiple of IKS Health is 32.5x. |
| What is the current revenue growth of IKS Health? | IKS Health revenue growth between 2023 and 2024 was 76%. |
| Is IKS Health profitable? | Yes, IKS Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
